Star Health and Allied Insurance Co. Ltd. Q1 FY27 Earnings Call Presentation

Star Health and Allied Insurance Co. Ltd. announced its Q1 FY27 Earnings Call Presentation, covering the quarter ended June 30, 2026. The presentation details the company’s financial performance, business landscape, and key strategic updates. Key highlights include robust growth in Gross Written Premium, improved underwriting results with a 97.0% CISR, and strong customer centricity metrics such as a 102% persistency. The company is focusing on sustainable profitable growth through disciplined portfolio management and technology-driven initiatives.

Star Health Announces Q1 FY27 Earnings Call Presentation

Star Health and Allied Insurance Company Limited has released its presentation for the Earnings Call pertaining to the First Quarter (Q1) of the Financial Year 2027 (FY27), which concluded on June 30, 2026. This presentation was made available to investors and analysts on Thursday, July 30, 2026, at 8:30 AM IST.

Key Financial Performance Highlights

The presented financials for Q1 FY27 showcase significant progress. The Combined Insurance Service Ratio (CISR) improved to 97.0% from 98.7% in Q1 FY26. The Underwriting Result saw a substantial increase to ₹111 crore, up from ₹16 crore in the previous year’s quarter. Profit After Tax (PAT) for Q1 FY27 stood at ₹550 crore, marking a 25% year-on-year growth. Return on Equity (ROE) also demonstrated strong performance, reaching 22.3% for Q1 FY27.

Progress on Key Business Metrics

Gross Premium has shown consistent growth, reaching ₹18,606 crore for FY26, with a projected trajectory for Q1 FY27. The Underwriting Result has moved from a negative ₹151 crore in FY25 to a positive ₹198 crore in FY26 and further to ₹111 crore in Q1 FY27. Normalised Profit After Tax also reflects positive momentum, with ₹1,222 crore in FY26 and ₹386 crore in Q1 FY27.

Business Landscape: Building a Distribution Moat

The company’s strategy revolves around building a compounding distribution moat. This is underpinned by a largest agency-led health distribution network built over two decades, a fast-growing Digital Direct-to-Customer (D2C) channel, and conscious risk-selection. The Granular Distribution strategy includes a large agency force of 8.5 Lakh agents, with 20,000 additions in Q1 FY27. The Scaling D2C Play is a profitable, fast-growing proprietary channel. The First-time Buyer Engine shows a high new-to-insurance mix of 94% in Q1 FY27. Furthermore, a Deep pan-India Footprint is evident, with non-metro geographies contributing over 60% of fresh business.

Capabilities: Technology-Driven Efficiency

Star Health leverages technology across its value chain to enhance outcomes. This includes twenty years of proprietary data on a unified data layer with AI/ML at scale. The Distribution App (ATOM Pro) enhances efficiencies with smart quotes and always-on dashboards, while the customer app catalyzes engagement across wellness and service touchpoints. Claims processing efficiency is strengthened with an intelligence layer, including generative AI embedded in claims processing and AI-ML powered architecture for mitigation of Fraud, Waste and Abuse (FWA).

ESG Initiatives

The company’s commitment to Environmental, Social, and Governance (ESG) principles is highlighted by an S&P Global CSA Score of 53 for FY25. Key initiatives include advancements in clean energy adoption, e-waste recycling, and digital resource conservation. Socially, Star Health focuses on 100% employee coverage under training programs, increased woman workforce representation (from 29% to 32%), and reduced employee attrition. Governance measures include reasonable assurance for core parameters and strengthened ESG governance.

CSR: Arogya Seva Kendra

The Corporate Social Responsibility (CSR) arm, Arogya Seva Kendra, is actively operating in 9 States, targeting outreach to over 1 million lives in underserved districts. Currently, there are 32 Operational Clinics, which have facilitated 56,794 visits. A total of 52,005 Medical Tests have been conducted, and 1,921 Pneumococcal vaccinations have been administered.

Source: BSE

Previous Article

Chalet Hotels Q1 FY27 Investor Presentation Highlights Robust Performance

Next Article

JSW Energy Limited O2 Renewable Energy XXIV Private Limited Secures "CARE A; Stable" Rating